ReinD.B., WittenbornJ.S., ZhangX., HoneycuttA.A., LesesneS.B., SaaddineJ.for the Vision Health Cost-Effectiveness Study Group. 2009. Forecasting age-related macular degeneration through the year 2050.The potential impact of new treatments. Arch. Ophthalmol., 127:533–540.
2.
ChewE.Y., ClemonsT., SanGiovanniJ.P., DanisR., DomalpallyA., McBeeW.et al.for AREDS2 Research Group. 2012. The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1)Ophthalmology, 119:2282–2289.
3.
BarakY., HeromanW.J., TezelT.H.2012. The past, present, and future of exudative age-related macular degeneration treatment. Middle East Afr. J. Ophthalmol., 19:43–51.
4.
MillerJ.W.2013. Age-related macular degeneration revisited – piecing the puzzle: the LXIX Edward Jackson memorial lecture. Am. J. Ophthalmol., 155:1–35.e13.
5.
HagstromS.A., YingG-S., PauerG.J.T.et al.for the Comparison of AMD Treatments Trials Research Group. 2013. Pharmacogenetics for genes associated with age-related macular degeneration in the comparison of AMD treatments trials (CATT)Ophthalmology, 120:593–599.
6.
EellsJ.T., Wong–RileyM.T., VerHoeveJ.et al.2004. Mitochondrial signal transduction in accelerated wound and retinal healing by near-infrared light therapy. Mitochondrion, 4:559–567.
7.
PeoplesC., ShawV.E., StoneJ., JefferyG., BakerG.E., MitrofanisJ.2012. Survival of dopaminergic amacrine cells after near-infrared light treatment in MPTP-treated mice. ISRN Neurol., 2012:850150.
8.
Rodríguez–SantanaE., ReyesH., Santana–RodríguezK.E., Santana–BlankL.2008. Photo-infrared pulsed biomodulation in age-related macular degeneration associated to neurological disease: one interventional case report and mini-review. J. Chinese Clin. Med., 3:470–477.
9.
Rodríguez–SantanaE., Santana–BlankL.A, Santana–RodríguezK.E.2011. Hypotensor effect of photo-infrared pulsed biomodulation over intraocular pressure. J. Chinese Clin. Med., 6:147–157.
10.
Santana–BlankL., Rodríguez–SantanaE., Santana–RodríguezJ.A., Santana–RodríguezK.E., ReyesH.2013. Laser photobiomodulation as a potential multi-target anticancer therapy-review. J. Solid Tumors, 3:50–62.
11.
Santana–BlankL., Rodríguez–SantanaE., Santana–RodríguezK.2010. Theoretic, experimental, clinical bases of the water oscillator hypothesis in near-infrared photobiomodulation. Photomed. Laser Surg., 28:S41–52.
12.
Santana-BlankL.A., Rodríguez–SantanaE., Santana–RodríguezK.E.2005. Photo-infrared pulsed bio-modulation (PIPBM): a novel mechanism for the enhancement of physiologically reparative responses. Photomed. Laser Surg., 23:416–424.
13.
TangJ., DuY., LeeC.A., TalahalliR., EellsJ.T., KernT.S.2013. Low-intensity far-red light inhibits early lesions that contribute to diabetic retinopathy: in vivo and in vitro. Invest. Ophthalmol. Vis. Sci., April4[Epub ahead of print].
14.
CampochiaroP.A.2013. Ocular neovascularization. J. Mol. Med. (Berl.), 91:311–321.
15.
PeplowP.V., ChungT.Y., RyanB., BaxterG.D.2011. Laser photobiomodulation of gene expression and release of growth factors and cytokines from cells in culture: a review of human and animal studies. Photomed Laser Surg., 29:285–304.
CostaF.F. 2010. Epigenomics in cancer management. Cancer Manag. Res., 2:255–265.
24.
JoyceK.M., DownesC.S., HanniganB.M.1999. Radioadaptation in Indian muntjac fibroblast cells induced by low intensity laser irradiation. Mutat Res., 435:35–42.
25.
GonzálezJ.A., Martin–LandroveM., CarboJ.R., ChacónM.1994. Bifurcations and chaos of DNA solitonic dynamics. International Centre for Theoretical Physics, 1–29.
